Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It also engages in exploration of Colchester East Natural Hydrogen Project comprising of 2,104 claims located within the Cumberland Basin in Nova Scotia; and the Timiskaming District of northern Ontario. It has a collaboration agreement with EIREX for the development and commercialization of EIREX's novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.
Frequently asked questions
What sector does Diagnamed Holdings Corp. (DMED) operate in?
Diagnamed Holdings Corp. belongs to the Other sector and operates in the Health Information Services industry.
What is Diagnamed Holdings Corp. (DMED) current stock price?
As of the latest data, Diagnamed Holdings Corp. stock price is CA$0.05, with a previous close of CA$0.06. Diagnamed Holdings Corp. lost -CA$0.01 in the last trading session, representing a -9.09% loss.
What is Diagnamed Holdings Corp. (DMED) current market capitalization?
Diagnamed Holdings Corp. market cap is approximately 6.58 million.
What is Diagnamed Holdings Corp. (DMED) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.02.
Does Diagnamed Holdings Corp. (DMED) pay dividends?
No. Diagnamed Holdings Corp. does not pay a dividend.
What is Diagnamed Holdings Corp. (DMED) beta (volatility) score?
Diagnamed Holdings Corp. has a beta of -1.283, indicating lower volatility than the overall market.
